NCT04668274View on ClinicalTrials.gov

JOTROL PK, Safety, and Food Effect Assessment

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 21, 2021

Primary Completion Date

February 28, 2021

Study Completion Date

May 31, 2021

Conditions
PharmacokineticsSafetyFood-drug Interaction
Interventions
DRUG

200 mg resveratrol as JOTROL

Low (first) dose of single ascending dose study

DRUG

500 mg resveratrol as JOTROL

Second (intermediate) dose of single ascending dose study

DRUG

700 mg resveratrol as JOTROL

Third (highest) dose of single ascending dose study

DRUG

500 mg resveratrol as JOTROL administered to assess influence of food

500 mg resveratrol as JOTROL administered to assess influence of food

Trial Locations (1)

33136

"inVentiv Health Clinical Research Services LLC, a Syneos Health company ( Syneos Health )", Miami

Sponsors
All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Jupiter Orphan Therapeutics Inc.

INDUSTRY